CRMD · CorMedix Inc.

$7.78 -0.64 (-7.60%) At close · Jul 20

Market Cap

$610.36M

78.45M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Todisco	CEO	$684,353	—	$4,492,500	—	$865,072	$59,251	$6,101,176
Beth Zelnick Kaufman	Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary	$497,596	—	$2,784,318	—	$435,941	$48,055	$3,765,910
Elizabeth Hurlburt	COO	$479,640	—	$2,784,318	—	$420,527	$59,203	$3,743,688

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Todisco	CEO	$639,214	—	$462,666	$745,788	$457,335	$54,906	$2,359,908
Elizabeth Hurlburt	Executive Vice President and Chief Operating Officer	$405,873	—	$173,500	$279,670	$223,344	$52,978	$1,135,365
Matthew David	CFO	$409,125	—	$173,500	$279,670	$171,171	$54,559	$1,088,025
Beth Zelnick Kaufman	Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary	$450,000	—	—	—	$217,800	$46,552	$714,352

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Todisco	CEO	$616,962	—	—	$1,388,400	$401,700	$52,370	$2,459,342
Phoebe Mounts	General Counsel	$375,000	—	—	$433,875	$112,500	$333,207	$1,254,582
Erin Mistry	SVP, Payer Strategy	$389,577	—	—	$694,200	$156,800	—	$1,240,577
Matthew David	CFO	$389,135	—	—	$433,875	$156,000	$52,140	$1,031,150

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joseph Todisco	CEO	$378,461	—	$701,245	$1,273,500	$305,760	$32,223	$2,691,189
Matthew David	CFO	$393,462	—	—	$305,900	$389,485	$47,697	$1,136,544
Phoebe Mounts	General Counsel	$375,000	—	—	$428,260	$195,075	$12,146	$1,010,481
Thomas Nusbickel	Chief Commercial Officer	$191,827	—	—	$305,900	$31,384	$416,766	$945,877
Elizabeth Hurlburt	Executive Vice President and Chief Operating Officer	$346,346	—	—	$305,900	$175,623	$16,942	$844,811

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Khoso Baluch	CEO	$366,700	—	—	$1,698,080	—	$531,393	$2,596,173
Thomas Nusbickel	Chief Commercial Officer	$233,654	$75,000	—	$1,540,265	—	$27,663	$1,876,582
Phoebe Mounts	General Counsel	$375,000	$61,875	—	$1,164,810	—	$11,412	$1,613,097
Matthew David	CFO	$351,923	$75,900	—	$951,895	—	$43,584	$1,423,302
John Armstrong	Analyst	$272,500	—	—	$742,910	—	$323,938	$1,339,348
Elizabeth Masson-Hurlburt	Executive Vice President for Clinical Operations	$310,800	$37,800	—	$742,910	—	$44,818	$1,136,328
Elizabeth Hurlburt	Executive Vice President and Chief Operating Officer	$310,800	$37,800	—	$742,910	—	$44,818	$1,136,328

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Khoso Baluch	CEO	$425,000	—	—	$428,583	$340,000	$40,088	$1,233,671
Matthew David	CFO	$209,423	—	—	$768,386	$99,000	$20,866	$1,097,675
Phoebe Mounts	General Counsel	$350,000	—	—	$408,070	$163,333	$9,745	$931,148
Elizabeth Masson-Hurlburt	Executive Vice President for Clinical Operations	$291,792	—	—	$332,420	$136,500	$35,561	$796,273
John Armstrong	Analyst	$322,635	—	—	$332,420	$112,875	$19,388	$787,318
Robert W. Cook	CFO	$242,403	—	—	—	—	$2,615	$245,018

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Khoso Baluch	CEO	$387,885	—	—	$1,133,600	$248,000	$26,344	$1,795,829
Phoebe Mounts	General Counsel	$232,885	—	—	$426,790	$84,000	$2,479	$746,154
Elizabeth Masson-Hurlburt	Executive Vice President for Clinical Operations	$280,000	—	—	$298,504	$67,200	$25,734	$671,438
John Armstrong	Analyst	$310,000	—	—	$57,195	$86,800	$11,001	$464,996
Matthew David	CFO	—	—	—	—	—	—	—

Key facts CIK 1410098 CUSIP 21900C308 13F (30d) 14 filings 14 filers Visit website Investor relations